Grow Therapy Raises Privacy Standards in Mental Health

New York, NY – [September 25, 2025] – Grow Therapy, a mental health platform that supports clinicians delivering in-person and virtual therapy and psychiatric care, today announced the acquisition of Neosync, a company focused on data privacy and security. The acquisition strengthens Grow’s existing privacy framework by advancing its data anonymization and synthetic data capabilities, positioning the company to raise the bar for safety-first analytics in behavioral healthcare.

Aaltan Ahmad, Head of Security, said, “At Grow Therapy we recognize that every piece of data represents a person’s story. Protecting that story is a core responsibility. We already maintain rigorous privacy standards, and integrating Neosync’s team and technology will accelerate our work to deliver safer analytics across the mental health ecosystem.”

Evis Drenova, Neosync Co-Founder and now Staff Product Manager at Grow, added, “We selected Grow because of their commitment to privacy. Joining Grow lets us scale Neosync’s anonymization and synthetic data tools within mental health care. Our approach creates fully anonymized datasets that preserve confidentiality while enabling research, quality improvement, and responsible innovation.”

Leveling Up Privacy

Recent client research conducted by Grow shows that privacy ranks among the top concerns for people seeking mental health services, just behind ease of access and convenience. Grow’s updated privacy strategy emphasizes three core principles that balance strong protections with practical clinical and research needs.

1. Trustworthy Innovation: Grow builds new features with privacy as a foundational design value. For example, Between-Session Reflections enables clients to write about their experiences and choose whether to share themes with their provider, keeping control in the client’s hands.
2. Strong Data Safeguards: Client data protection is central to Grow’s product and engineering decisions. Personal identifiers are removed and synthetic data models are used to support product development, testing, and analytics without exposing individual records.
3. Consent First: Advanced tools, such as AI-assisted draft notes and client visit summaries, activate only with explicit consent from both client and clinician. Participation is optional, and Grow’s current practice does not retain raw transcripts of therapy conversations long-term.

Why This Matters Now

Stigma and fear of exposure continue to create barriers to mental health care in the United States. For many people, assurance of privacy and confidentiality determines whether they will seek help. By investing in privacy engineering and anonymization, Grow aims to make care safer and more accessible.

Confidentiality has long been a pillar of therapeutic practice. At the same time, a growing number of generic chatbots and health apps operate without robust privacy commitments, creating risk for users and eroding trust in digital health tools. As Grow develops its own AI capabilities, the company has committed to hold those systems to clinical-grade privacy and security standards rather than the looser norms common in consumer apps.

With the Health Insurance Portability and Accountability Act (HIPAA) approaching its 30th anniversary in 2026, Grow points out that many regulatory frameworks were not designed for today’s digital landscape. The company believes there is an opportunity to innovate in privacy and governance: safer-by-design analytics and rigorous anonymization can enable research, product improvement, and machine learning while minimizing the chance of re-identification or unintended exposure.

By integrating Neosync’s techniques—such as masking, privacy-preserving synthetic data, and governance tools—Grow intends to create safer test environments and produce realistic datasets that do not require access to identifiable health information. This approach supports clinical quality improvement, research, and engineering work while keeping client confidentiality central.

Media Contact:
Kristina McPherson
[email protected]